To complete acquisition by 31 March 2017
Dr Lal PathLabs announced that the Company is in the process of completing the due diligence and legal documentation for the acquisition of 100% stake in Delta Ria & Pathology, post which it expects to complete the acquisition by 31 March 2017.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
